Pub Date : 2024-10-01Epub Date: 2024-05-30DOI: 10.1037/pha0000728
Vishnu Shivam
The objective of this study is to review the association of TAS2R38 polymorphisms and taste phenotypes to bitter compounds (phenylthiocarbamide [PTC]/propylthiouracil [PROP]), and its association among persons who drink alcohol and individuals with smoking behavior. A literature search was carried out in PubMed, ScienceDirect, Cochrane, and Wiley online library databases using the keyword "(Bitter taste receptor genes OR TAS2R38) AND (PROP OR propylthiouracil) AND (PTC OR phenylthiocarbamide)," "(Bitter taste receptor genes OR TAS2R38) AND (alcohol)," "(Bitter taste receptor genes OR TAS2R38) AND (tobacco OR smoker)" to find articles evaluating the association of taste phenotypes and TAS2R38 polymorphisms, and its association among persons who drink alcohol and individuals with smoking behavior. The analysis show that TAS2R38 taster genotype (proline-alanine-valine [PAV] allele) was significantly (OR, 5.88; CI [3.87, 8.95], p < .001) associated with taster phenotype for bitter compounds (PTC/PROP), and TAS2R38 nontaster genotype (alanine-valine-isoleucine allele) was significantly (OR, 6.73; CI [4.57, 9.90], p < .001) associated with nontaster phenotype for bitter compounds. Further, TAS2R38 taster genotypes (PAV homozygotes and heterozygotes) were significantly associated with higher alcohol intake (OR, 5.15; 95% CI [2.66, 9.98]; p < .001) and among individuals with smoking behavior (OR, 1.73; 95% CI [1.24, 2.42]; p = .001). This suggests that TAS2R38 single nucleotide polymorphisms can be identified by clinically assessing taste phenotype status for bitter compounds and can be used as a potential therapeutic target in the prevention and treatment of harmful higher alcohol intake and smoking behavior. (PsycInfo Database Record (c) 2024 APA, all rights reserved).
本研究旨在回顾 TAS2R38 多态性与苦味化合物(苯硫基甲酰胺 [PTC] / 丙基硫脲嘧啶 [PROP])味觉表型的相关性,及其与饮酒者和有吸烟行为者的相关性。在 PubMed、ScienceDirect、Cochrane 和 Wiley 在线图书馆数据库中使用关键词"(苦味受体基因或 TAS2R38)和(PROP 或丙基硫脲嘧啶)和(PTC 或苯硫代甲酰胺)"、"(苦味受体基因或 TAS2R38)和(酒精)"进行了文献检索、"(苦味受体基因或 TAS2R38)与(烟草或吸烟者)",以查找评估味觉表型与 TAS2R38 多态性之间关系的文章,及其与饮酒者和有吸烟行为者之间关系的文章。分析表明,TAS2R38 味觉基因型(脯氨酸-丙氨酸-缬氨酸 [PAV] 等位基因)与味觉表型显著相关(OR, 5.88; CI [3.87, 8.95], p < .001)与苦味化合物的品尝表型(PTC/PROP)相关,而 TAS2R38 非品尝基因型(丙氨酸-缬氨酸-异亮氨酸等位基因)与苦味化合物的非品尝表型显著相关(OR,6.73;CI [4.57,9.90],p < .001)。此外,TAS2R38品尝基因型(PAV同源染色体和杂合染色体)与较高的酒精摄入量(OR,5.15;95% CI [2.66,9.98];p < .001)和吸烟行为(OR,1.73;95% CI [1.24,2.42];p = .001)显著相关。这表明,TAS2R38单核苷酸多态性可通过临床评估苦味化合物的味觉表型状态来确定,并可作为预防和治疗有害的高酒精摄入量和吸烟行为的潜在治疗靶点。(PsycInfo Database Record (c) 2024 APA, 版权所有)。
{"title":"A meta-analysis on polymorphic trait of taste perception mediated by TAS2R38 genotype.","authors":"Vishnu Shivam","doi":"10.1037/pha0000728","DOIUrl":"10.1037/pha0000728","url":null,"abstract":"<p><p>The objective of this study is to review the association of TAS2R38 polymorphisms and taste phenotypes to bitter compounds (phenylthiocarbamide [PTC]/propylthiouracil [PROP]), and its association among persons who drink alcohol and individuals with smoking behavior. A literature search was carried out in PubMed, ScienceDirect, Cochrane, and Wiley online library databases using the keyword \"(Bitter taste receptor genes OR TAS2R38) AND (PROP OR propylthiouracil) AND (PTC OR phenylthiocarbamide),\" \"(Bitter taste receptor genes OR TAS2R38) AND (alcohol),\" \"(Bitter taste receptor genes OR TAS2R38) AND (tobacco OR smoker)\" to find articles evaluating the association of taste phenotypes and TAS2R38 polymorphisms, and its association among persons who drink alcohol and individuals with smoking behavior. The analysis show that TAS2R38 taster genotype (proline-alanine-valine [PAV] allele) was significantly (OR, 5.88; CI [3.87, 8.95], <i>p</i> < .001) associated with taster phenotype for bitter compounds (PTC/PROP), and TAS2R38 nontaster genotype (alanine-valine-isoleucine allele) was significantly (OR, 6.73; CI [4.57, 9.90], <i>p</i> < .001) associated with nontaster phenotype for bitter compounds. Further, TAS2R38 taster genotypes (PAV homozygotes and heterozygotes) were significantly associated with higher alcohol intake (OR, 5.15; 95% CI [2.66, 9.98]; <i>p</i> < .001) and among individuals with smoking behavior (OR, 1.73; 95% CI [1.24, 2.42]; <i>p</i> = .001). This suggests that TAS2R38 single nucleotide polymorphisms can be identified by clinically assessing taste phenotype status for bitter compounds and can be used as a potential therapeutic target in the prevention and treatment of harmful higher alcohol intake and smoking behavior. (PsycInfo Database Record (c) 2024 APA, all rights reserved).</p>","PeriodicalId":12089,"journal":{"name":"Experimental and clinical psychopharmacology","volume":" ","pages":"497-505"},"PeriodicalIF":2.4,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141179328","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-10-01Epub Date: 2024-05-30DOI: 10.1037/pha0000719
Alison J Patev, Madison Combs, Nicoleta Gaitan, Nareg Karaoghlanian, Thokozeni Lipato, Thomas Eissenberg, Alison Breland
Nicotine flux, the rate of electronic nicotine delivery system (ENDS) nicotine emission, is important in determining ENDS abuse liability. However, flux does not account for user behavior, including puff duration. Along with nicotine flux, puff duration limits the dose of nicotine that can be inhaled. Controlling both flux and puff duration allows regulators to constrain nicotine dose effectively. This study examined the effects of differing ENDS nicotine fluxes (by manipulating liquid nicotine concentration and holding device power constant), with user puff duration limited to 2 s. Participants (N = 32) completed four sessions, each session differing by nicotine flux (no flux, low flux, cigarettelike flux, and high flux conditions). Participants completed two ENDS use bouts in each session while puff duration was limited to 2 s. Plasma nicotine concentration, heart rate, and subjective effects were measured. At higher flux, higher plasma nicotine concentration and higher heart rate were observed. Moreover, higher fluxes decreased ratings of craving and urge to use nicotine and increased positive subjective effects, such as calmness. This study demonstrates that by manipulating nicotine flux and limiting puff duration, nicotine dose can be controlled. Subsequent research should demonstrate the effects of manipulating puff duration systematically. Results underscore the importance of targeting both flux and puff duration for ENDS regulation, intended to reduce abuse liability while maintaining the potential to facilitate transitions from cigarettes to ENDS. (PsycInfo Database Record (c) 2024 APA, all rights reserved).
尼古丁通量,即电子尼古丁释放系统(ENDS)尼古丁释放的速度,对于确定ENDS滥用责任非常重要。然而,尼古丁通量并不考虑使用者的行为,包括吸食时间。除尼古丁通量外,持续时间也限制了可吸入的尼古丁剂量。同时控制尼古丁通量和吸食持续时间可使监管机构有效限制尼古丁剂量。本研究考察了不同ENDS尼古丁通量(通过调节液体尼古丁浓度并保持设备功率不变)的影响,同时将使用者的吸气时间限制在2秒。参与者(32人)完成了四个疗程,每个疗程的尼古丁通量不同(无通量、低通量、类似香烟通量和高通量条件)。参与者在每个疗程中完成两次ENDS使用,同时将吸入时间限制在2秒钟内。在较高的通量下,观察到较高的血浆尼古丁浓度和较高的心率。此外,较高的通量可降低对尼古丁的渴求度和使用尼古丁的冲动,并增加积极的主观效应,如平静。这项研究表明,通过操纵尼古丁通量和限制吸食时间,可以控制尼古丁剂量。后续研究应系统地证明操纵抽吸时间的效果。研究结果强调了针对尼古丁通量和吸食持续时间进行 ENDS 监管的重要性,其目的是减少滥用责任,同时保持促进从香烟过渡到 ENDS 的潜力。(PsycInfo Database Record (c) 2024 APA,保留所有权利)。
{"title":"Constraining electronic nicotine delivery systems (ENDS) nicotine dose by controlling nicotine flux at a limited puff duration.","authors":"Alison J Patev, Madison Combs, Nicoleta Gaitan, Nareg Karaoghlanian, Thokozeni Lipato, Thomas Eissenberg, Alison Breland","doi":"10.1037/pha0000719","DOIUrl":"10.1037/pha0000719","url":null,"abstract":"<p><p>Nicotine flux, the rate of electronic nicotine delivery system (ENDS) nicotine emission, is important in determining ENDS abuse liability. However, flux does not account for user behavior, including puff duration. Along with nicotine flux, puff duration limits the dose of nicotine that can be inhaled. Controlling both flux and puff duration allows regulators to constrain nicotine dose effectively. This study examined the effects of differing ENDS nicotine fluxes (by manipulating liquid nicotine concentration and holding device power constant), with user puff duration limited to 2 s. Participants (<i>N</i> = 32) completed four sessions, each session differing by nicotine flux (no flux, low flux, cigarettelike flux, and high flux conditions). Participants completed two ENDS use bouts in each session while puff duration was limited to 2 s. Plasma nicotine concentration, heart rate, and subjective effects were measured. At higher flux, higher plasma nicotine concentration and higher heart rate were observed. Moreover, higher fluxes decreased ratings of craving and urge to use nicotine and increased positive subjective effects, such as calmness. This study demonstrates that by manipulating nicotine flux and limiting puff duration, nicotine dose can be controlled. Subsequent research should demonstrate the effects of manipulating puff duration systematically. Results underscore the importance of targeting both flux and puff duration for ENDS regulation, intended to reduce abuse liability while maintaining the potential to facilitate transitions from cigarettes to ENDS. (PsycInfo Database Record (c) 2024 APA, all rights reserved).</p>","PeriodicalId":12089,"journal":{"name":"Experimental and clinical psychopharmacology","volume":" ","pages":"604-614"},"PeriodicalIF":2.4,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141179403","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-10-01Epub Date: 2024-05-30DOI: 10.1037/pha0000726
Alexander Soutschek, Charlotte E Wittekind
Tobacco dependence is characterized by decision-making impairments, which may increase the risk of smoking relapse by lowering the capacity to resist the immediate gratification of nicotine consumption. Because controlling one's desires for immediate rewards is experienced as effortful, aversion to effortful control processes may also influence the prospects of successful smoking cessation. We therefore tested whether persons who smoke, compared with persons who do not smoke, show a lower willingness to engage in goal-directed mental effort. Thirty-seven persons who smoke and 38 persons who do not smoke performed a decision task requiring choices on whether to exert a demanding attention task for monetary rewards. Using state-of-the-art drift-diffusion modeling, we found that persons who smoke showed a stronger starting bias toward effort-free rewards. Taken together, our process model approach allowed us to identify the subcomponents of the decision process underlying the stronger aversion against mental effort in tobacco dependence, which may contribute to altered decision making by lowering the motivation to engage in effortful control processes when trying to suppress the desire for nicotine consumption. (PsycInfo Database Record (c) 2024 APA, all rights reserved).
烟草依赖的特点是决策障碍,这可能会降低抵制尼古丁消费带来的即时满足感的能力,从而增加复吸的风险。由于控制自己对即时回报的欲望是一种费力的体验,因此厌恶费力的控制过程也可能影响成功戒烟的前景。因此,我们测试了吸烟者与不吸烟者相比,是否表现出较低的目标导向心理努力意愿。37名吸烟者和38名不吸烟者进行了一项决策任务,要求他们选择是否为了金钱奖励而付出高要求的注意力。通过使用最先进的漂移-扩散模型,我们发现吸烟者在开始时更偏向于不费力的奖励。总之,我们的过程模型方法使我们能够确定烟草依赖者对脑力劳动产生更强烈厌恶的决策过程的子成分,这可能会在试图抑制尼古丁消费欲望时降低参与努力控制过程的动机,从而导致决策的改变。(PsycInfo Database Record (c) 2024 APA, 版权所有)。
{"title":"Lower motivation for rewarded mental effort in tobacco dependence.","authors":"Alexander Soutschek, Charlotte E Wittekind","doi":"10.1037/pha0000726","DOIUrl":"10.1037/pha0000726","url":null,"abstract":"<p><p>Tobacco dependence is characterized by decision-making impairments, which may increase the risk of smoking relapse by lowering the capacity to resist the immediate gratification of nicotine consumption. Because controlling one's desires for immediate rewards is experienced as effortful, aversion to effortful control processes may also influence the prospects of successful smoking cessation. We therefore tested whether persons who smoke, compared with persons who do not smoke, show a lower willingness to engage in goal-directed mental effort. Thirty-seven persons who smoke and 38 persons who do not smoke performed a decision task requiring choices on whether to exert a demanding attention task for monetary rewards. Using state-of-the-art drift-diffusion modeling, we found that persons who smoke showed a stronger starting bias toward effort-free rewards. Taken together, our process model approach allowed us to identify the subcomponents of the decision process underlying the stronger aversion against mental effort in tobacco dependence, which may contribute to altered decision making by lowering the motivation to engage in effortful control processes when trying to suppress the desire for nicotine consumption. (PsycInfo Database Record (c) 2024 APA, all rights reserved).</p>","PeriodicalId":12089,"journal":{"name":"Experimental and clinical psychopharmacology","volume":" ","pages":"615-623"},"PeriodicalIF":2.4,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141179411","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-08-01Epub Date: 2024-05-09DOI: 10.1037/pha0000714
Adysn Kilty, Yvonne Lucas, Caroline Kukas, Sarah Siudut, Joseph R Troisi
Nicotine functions effectively as an interoceptive operant discriminative stimulus (SD) that sets the occasion for voluntarily emitted behavior to be reinforced by biologically relevant outcomes (e.g., food). This has been demonstrated primarily with male rats. Far less is known about nicotine's operant SD functions in female rats. There are no reports of sex differences in extinction and recovery of the SD functions of nicotine, which may elucidate smoking cessation and relapse. In view of this, eight male and eight female rats were trained to nose poke differentially among quasirandomly intermixed sessions of food reinforcement variable interval (VI-30 s) and nonreinforcement in a go/no-go across session one-manipulanda operant drug discrimination procedure. For half the rats, presession administration of nicotine (0.30 mg/kg, subcutaneous) occasioned reinforcement sessions of nose pokes (i.e., SD); for the remaining rats, it occasioned nonreinforcement (SΔ). Saline sessions occasioned the opposite contingencies. Training was conducted first under feeding restriction and then under free feeding, which was then followed by extinction sessions that were also conducted with free feeding. During discrimination training, response rates for females did not differ from males when conducted under restricted feeding but did so during training and later extinction conducted under free feeding. Females also exhibited greater reinstatement of responding under the nicotine SD but not the SΔ. These data provide additional evidence for sex differences in rats with the discriminative stimulus functions of nicotine under low, but not high, food-drive states-and may have implications for sex/gender differences in smoking cessation and relapse. (PsycInfo Database Record (c) 2024 APA, all rights reserved).
{"title":"Sex differences in extinction and reinstatement of nicotine discrimination in rats: The effects of reinforcer devaluation.","authors":"Adysn Kilty, Yvonne Lucas, Caroline Kukas, Sarah Siudut, Joseph R Troisi","doi":"10.1037/pha0000714","DOIUrl":"10.1037/pha0000714","url":null,"abstract":"<p><p>Nicotine functions effectively as an interoceptive operant discriminative stimulus (S<sup>D</sup>) that sets the occasion for voluntarily emitted behavior to be reinforced by biologically relevant outcomes (e.g., food). This has been demonstrated primarily with male rats. Far less is known about nicotine's operant S<sup>D</sup> functions in female rats. There are no reports of sex differences in extinction and recovery of the SD functions of nicotine, which may elucidate smoking cessation and relapse. In view of this, eight male and eight female rats were trained to nose poke differentially among quasirandomly intermixed sessions of food reinforcement variable interval (VI-30 s) and nonreinforcement in a go/no-go across session one-manipulanda operant drug discrimination procedure. For half the rats, presession administration of nicotine (0.30 mg/kg, subcutaneous) occasioned reinforcement sessions of nose pokes (i.e., S<sup>D</sup>); for the remaining rats, it occasioned nonreinforcement (S<sup>Δ</sup>). Saline sessions occasioned the opposite contingencies. Training was conducted first under feeding restriction and then under free feeding, which was then followed by extinction sessions that were also conducted with free feeding. During discrimination training, response rates for females did not differ from males when conducted under restricted feeding but did so during training and later extinction conducted under free feeding. Females also exhibited greater reinstatement of responding under the nicotine S<sup>D</sup> but not the S<sup>Δ</sup>. These data provide additional evidence for sex differences in rats with the discriminative stimulus functions of nicotine under low, but not high, food-drive states-and may have implications for sex/gender differences in smoking cessation and relapse. (PsycInfo Database Record (c) 2024 APA, all rights reserved).</p>","PeriodicalId":12089,"journal":{"name":"Experimental and clinical psychopharmacology","volume":" ","pages":"428-435"},"PeriodicalIF":2.4,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140897376","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-08-01Epub Date: 2023-11-02DOI: 10.1037/pha0000690
Bonnie H P Rowland, Jianna Iaciofano, Tibor P Palfai
Heavy episodic drinking (HED) is common among college students and poses risks for negative consequences. Evidence suggests that HED is more frequent among those with stronger implicit alcohol associations, and the impact of these implicit associations on drinking may be moderated by executive functioning. This study examined the role of two executive function components-working memory (WM) and planning-as moderators of implicit alcohol-approach associations and HED among college students who drink alcohol. One hundred forty-one participants completed measures of alcohol use, implicit alcohol-approach associations, WM, and planning. Regression analyses were conducted to examine the respective two-way and three-way interactions between implicit alcohol associations, WM, and planning on HED. Results showed that WM and planning each moderated the relation between alcohol implicit association test (IAT) and HED. IAT scores were positively associated with HED when WM and planning were low (-1 SD) but not high (+1 SD). Although results from the three-way interaction exhibited a nonsignificant trend, the pattern of results showed that the association between IAT and HED was stronger at lower levels of WM, but only when planning was also low, not high. Findings support the view that HED among college students who drink alcohol may be a function of automatic alcohol associations and that these associations may be stronger among those with lower WM and planning abilities. These results replicate and extend our understanding of how executive functioning may moderate the impact of implicit alcohol cognitions on risky drinking and suggests potential intervention targets. (PsycInfo Database Record (c) 2024 APA, all rights reserved).
{"title":"How executive functioning moderates the relation between implicit alcohol associations and heavy episodic drinking: The roles of planning and working memory.","authors":"Bonnie H P Rowland, Jianna Iaciofano, Tibor P Palfai","doi":"10.1037/pha0000690","DOIUrl":"10.1037/pha0000690","url":null,"abstract":"<p><p>Heavy episodic drinking (HED) is common among college students and poses risks for negative consequences. Evidence suggests that HED is more frequent among those with stronger implicit alcohol associations, and the impact of these implicit associations on drinking may be moderated by executive functioning. This study examined the role of two executive function components-working memory (WM) and planning-as moderators of implicit alcohol-approach associations and HED among college students who drink alcohol. One hundred forty-one participants completed measures of alcohol use, implicit alcohol-approach associations, WM, and planning. Regression analyses were conducted to examine the respective two-way and three-way interactions between implicit alcohol associations, WM, and planning on HED. Results showed that WM and planning each moderated the relation between alcohol implicit association test (IAT) and HED. IAT scores were positively associated with HED when WM and planning were low (-1 SD) but not high (+1 <i>SD</i>). Although results from the three-way interaction exhibited a nonsignificant trend, the pattern of results showed that the association between IAT and HED was stronger at lower levels of WM, but only when planning was also low, not high. Findings support the view that HED among college students who drink alcohol may be a function of automatic alcohol associations and that these associations may be stronger among those with lower WM and planning abilities. These results replicate and extend our understanding of how executive functioning may moderate the impact of implicit alcohol cognitions on risky drinking and suggests potential intervention targets. (PsycInfo Database Record (c) 2024 APA, all rights reserved).</p>","PeriodicalId":12089,"journal":{"name":"Experimental and clinical psychopharmacology","volume":" ","pages":"379-385"},"PeriodicalIF":2.4,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"71421987","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-08-01Epub Date: 2024-02-08DOI: 10.1037/pha0000707
Bryant M Stone, Jonathan J Hammersley, Norka E Rabinovich, David G Gilbert
In contrast to overnight deprivation versus satiety studies, a small number of placebo-controlled studies have failed to find that nicotine administration reduces attentional bias (AB) to smoking cues. To assess the reliability of this failure and to address the duration and salience of AB in smokers versus never-smokers, we used a longer-than-typical (i.e., 3,000 ms) smoking cue-presentation time in a placebo-controlled trial of smokers and never-smokers. We aimed to assess whether a nicotine patch (i.e., active vs. placebo) attenuates continuously assessed eye gaze-measured AB to smoking cues across 3,000 ms in 32 habitual, overnight-deprived smokers and smoker-nonsmoker differences compared to 32 never-smokers. We presented a series of picture pairs (i.e., one smoking-related and one affectively neutral control picture) simultaneously to assess AB. Participants attended a 14 mg nicotine patch and a placebo patch session in a randomized order. The habitual smokers were 12-18 hr nicotine-deprived during both sessions. Smokers demonstrated a stronger AB toward smoking cues than never-smokers across the entire 3,000 ms cue-presentation time. Nicotine did not significantly reduce the AB to smoking cues but the AB was strongly and positively related to deprivation-associated cravings in smokers. Patch-delivered nicotine did not reduce AB to smoking cues presented for up to 3,000 ms, even though smoker-nonsmoker differences in bias remained. Assessments of longer cue presentations and more subtle cues may provide nuance not currently captured by existing studies, because of potential demand effects in designs that contrast overnight versus sated state effects on AB. (PsycInfo Database Record (c) 2024 APA, all rights reserved).
与过夜剥夺与饱腹感研究不同的是,少量安慰剂对照研究未能发现尼古丁给药能减少对吸烟提示的注意偏差(AB)。为了评估这种失败的可靠性,并解决吸烟者与从不吸烟者注意力偏差的持续时间和显著性问题,我们在吸烟者和从不吸烟者的安慰剂对照试验中使用了比典型时间更长(即 3,000 毫秒)的吸烟线索呈现时间。我们的目的是评估尼古丁贴片(即活性贴片与安慰剂贴片)与 32 名从不吸烟者相比,是否会在 3,000 毫秒内减弱连续评估的眼球注视测量的吸烟提示 AB 值。我们同时展示了一系列图片对(即一张与吸烟相关的图片和一张情感中性的对照图片)来评估 AB。参与者按随机顺序参加了 14 毫克尼古丁贴片和安慰剂贴片的测试。在这两个环节中,习惯吸烟者的尼古丁缺失时间均为 12-18 小时。在整个 3,000 毫秒的线索呈现时间内,吸烟者比从不吸烟者对吸烟线索表现出更强的 AB。尼古丁并未明显降低吸烟者对吸烟暗示的AB值,但吸烟者的AB值与剥夺相关的渴求度呈强烈的正相关。虽然吸烟者与非吸烟者在偏差上的差异仍然存在,但贴片尼古丁并没有减少吸烟提示呈现时间长达 3,000 毫秒时的 AB 值。对时间更长的提示和更微妙的提示进行评估可能会提供现有研究无法捕捉到的细微差别,因为在设计中对比了隔夜和饱食状态对 AB 的影响,可能会产生需求效应。(PsycInfo Database Record (c) 2024 APA,保留所有权利)。
{"title":"Effects of nicotine patches on early and late attentional bias to smoking cues: We may know less than we think.","authors":"Bryant M Stone, Jonathan J Hammersley, Norka E Rabinovich, David G Gilbert","doi":"10.1037/pha0000707","DOIUrl":"10.1037/pha0000707","url":null,"abstract":"<p><p>In contrast to overnight deprivation versus satiety studies, a small number of placebo-controlled studies have failed to find that nicotine administration reduces attentional bias (AB) to smoking cues. To assess the reliability of this failure and to address the duration and salience of AB in smokers versus never-smokers, we used a longer-than-typical (i.e., 3,000 ms) smoking cue-presentation time in a placebo-controlled trial of smokers and never-smokers. We aimed to assess whether a nicotine patch (i.e., active vs. placebo) attenuates continuously assessed eye gaze-measured AB to smoking cues across 3,000 ms in 32 habitual, overnight-deprived smokers and smoker-nonsmoker differences compared to 32 never-smokers. We presented a series of picture pairs (i.e., one smoking-related and one affectively neutral control picture) simultaneously to assess AB. Participants attended a 14 mg nicotine patch and a placebo patch session in a randomized order. The habitual smokers were 12-18 hr nicotine-deprived during both sessions. Smokers demonstrated a stronger AB toward smoking cues than never-smokers across the entire 3,000 ms cue-presentation time. Nicotine did not significantly reduce the AB to smoking cues but the AB was strongly and positively related to deprivation-associated cravings in smokers. Patch-delivered nicotine did not reduce AB to smoking cues presented for up to 3,000 ms, even though smoker-nonsmoker differences in bias remained. Assessments of longer cue presentations and more subtle cues may provide nuance not currently captured by existing studies, because of potential demand effects in designs that contrast overnight versus sated state effects on AB. (PsycInfo Database Record (c) 2024 APA, all rights reserved).</p>","PeriodicalId":12089,"journal":{"name":"Experimental and clinical psychopharmacology","volume":" ","pages":"453-464"},"PeriodicalIF":2.4,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139706425","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-08-01Epub Date: 2023-12-21DOI: 10.1037/pha0000703
Mary Takgbajouah, Nate Barnes, James MacKillop, James G Murphy, Joanna Buscemi
Previous research has shown that (ACEs) are associated with negative health outcomes, including depression, problematic alcohol use, and disordered patterns of overeating, including food addiction (FA). Moreover, anhedonia, or an inability to feel pleasure, has been also shown to increase risk for problematic alcohol use, as well as FA. It is possible that anhedonia may be implicated in health risk behaviors as individuals with anhedonia may seek out highly hedonic activities. The purpose of the present study was to explore the direct and indirect relationship between ACEs and alcohol use disorder (AUD) and FA symptoms via anhedonia in a diverse sample of emerging adults with histories of heavy drinking. A cross-sectional, quantitative design was used. The sample was 42.6% male, 45.5% White, and 39.9% Black, and the average age of participants was 22.64 (SD = 1.01). A confirmatory factor analysis was used to specify the model, and structural equation modeling was used to test the hypotheses. The initial measurement model was overidentified and demonstrated acceptable to favorable fit. Standardized results from a bootstrap analysis of the structural regression model showed significant direct effects of ACEs on FA and AUD symptoms. Results also found a significant indirect effect of ACEs on AUD symptoms through anhedonia, though this indirect effect was not significant for FA. Anhedonia could be a key target for the prevention and treatment of problematic alcohol use. Future research should examine the role of anhedonia in the maintenance of FA in nonheavy drinking samples. (PsycInfo Database Record (c) 2024 APA, all rights reserved).
以往的研究表明,(ACE)与负面的健康结果有关,包括抑郁、酗酒和无序的暴饮暴食模式,包括食物成瘾(FA)。此外,失乐症或无法感受快乐也被证明会增加酗酒和食物成瘾的风险。失乐症可能与健康风险行为有关,因为失乐症患者可能会寻求高享乐性的活动。本研究的目的是通过对有大量饮酒史的不同新兴成人样本进行研究,探讨 ACE 与酒精使用障碍(AUD)和失乐症状之间的直接和间接关系。研究采用横断面定量设计。样本中有 42.6% 的男性、45.5% 的白人和 39.9% 的黑人,参与者的平均年龄为 22.64 岁(SD = 1.01)。采用确认性因素分析来确定模型,并采用结构方程模型来检验假设。最初的测量模型被过度识别,并显示出可以接受的良好拟合度。结构回归模型的自举分析标准化结果显示,ACE 对 FA 和 AUD 症状有显著的直接影响。结果还发现,ACE 通过失乐症对 AUD 症状有明显的间接影响,但这种间接影响对 FA 并不明显。失乐症可能是预防和治疗问题性饮酒的一个关键目标。未来的研究应考察失乐症在非大量饮酒样本中维持 FA 的作用。(PsycInfo Database Record (c) 2023 APA,保留所有权利)。
{"title":"The role of anhedonia in the relationship between adverse childhood experiences (ACEs), alcohol use disorder symptoms, and food addiction symptoms in a sample of emerging adults with histories of heavy drinking.","authors":"Mary Takgbajouah, Nate Barnes, James MacKillop, James G Murphy, Joanna Buscemi","doi":"10.1037/pha0000703","DOIUrl":"10.1037/pha0000703","url":null,"abstract":"<p><p>Previous research has shown that (ACEs) are associated with negative health outcomes, including depression, problematic alcohol use, and disordered patterns of overeating, including food addiction (FA). Moreover, anhedonia, or an inability to feel pleasure, has been also shown to increase risk for problematic alcohol use, as well as FA. It is possible that anhedonia may be implicated in health risk behaviors as individuals with anhedonia may seek out highly hedonic activities. The purpose of the present study was to explore the direct and indirect relationship between ACEs and alcohol use disorder (AUD) and FA symptoms via anhedonia in a diverse sample of emerging adults with histories of heavy drinking. A cross-sectional, quantitative design was used. The sample was 42.6% male, 45.5% White, and 39.9% Black, and the average age of participants was 22.64 (<i>SD</i> = 1.01). A confirmatory factor analysis was used to specify the model, and structural equation modeling was used to test the hypotheses. The initial measurement model was overidentified and demonstrated acceptable to favorable fit. Standardized results from a bootstrap analysis of the structural regression model showed significant direct effects of ACEs on FA and AUD symptoms. Results also found a significant indirect effect of ACEs on AUD symptoms through anhedonia, though this indirect effect was not significant for FA. Anhedonia could be a key target for the prevention and treatment of problematic alcohol use. Future research should examine the role of anhedonia in the maintenance of FA in nonheavy drinking samples. (PsycInfo Database Record (c) 2024 APA, all rights reserved).</p>","PeriodicalId":12089,"journal":{"name":"Experimental and clinical psychopharmacology","volume":" ","pages":"418-427"},"PeriodicalIF":2.4,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138828986","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-08-01Epub Date: 2024-05-09DOI: 10.1037/pha0000724
Brian R Katz, Diann E Gaalema, Julie A Dumas, Sarah H Heil, Stacey C Sigmon, Jennifer W Tidey, Dustin C Lee, Michael DeSarno, Stephen T Higgins
Reductions in the nicotine content of cigarettes decrease smoking rate and dependence severity, but effects on cognition are less well established. The potential impacts of very-low nicotine-content (VLNC) cigarettes on cognitive task performance must be evaluated, especially in vulnerable populations. The aim of the present study is to experimentally examine the effects of VLNC cigarettes on cognitive performance. Adults who smoked daily (n = 775) from three vulnerable populations (socioeconomically disadvantaged reproductive-age women, individuals with opioid use disorder, affective disorders) were examined. Participants were randomly assigned to normal nicotine content (NNC; 15.8 mg nicotine/g tobacco) or VLNC (2.4 mg/g or 0.4 mg/g) cigarettes for 12 weeks. Response inhibition (stop-signal task), working memory (n-back task; n of 2-n of 0), and cognitive interference (nicotine Stroop task) were assessed at baseline, 2, 6, and 12 weeks. Results were analyzed using mixed-model repeated-measures analyses of variance. Extended exposure to VLNC cigarettes produced no significant changes in any measure of cognitive performance compared to NNC cigarettes. Over weeks, response times on the n-back task decreased across doses. No significant effects were observed on the stop-signal or nicotine Stroop tasks. All three vulnerable populations performed comparably on all three cognitive tasks. Extended exposure to VLNC cigarettes produced no impairments in cognitive performance on any of the assessed tasks compared to NNC cigarettes. These findings are consistent with the larger literature detailing other consequences following exposure to VLNC cigarettes and are encouraging for the adoption of a nicotine-reduction policy. (PsycInfo Database Record (c) 2024 APA, all rights reserved).
{"title":"Cigarette smoking and cognitive task performance: Experimental effects of very-low nicotine-content cigarettes.","authors":"Brian R Katz, Diann E Gaalema, Julie A Dumas, Sarah H Heil, Stacey C Sigmon, Jennifer W Tidey, Dustin C Lee, Michael DeSarno, Stephen T Higgins","doi":"10.1037/pha0000724","DOIUrl":"10.1037/pha0000724","url":null,"abstract":"<p><p>Reductions in the nicotine content of cigarettes decrease smoking rate and dependence severity, but effects on cognition are less well established. The potential impacts of very-low nicotine-content (VLNC) cigarettes on cognitive task performance must be evaluated, especially in vulnerable populations. The aim of the present study is to experimentally examine the effects of VLNC cigarettes on cognitive performance. Adults who smoked daily (<i>n</i> = 775) from three vulnerable populations (socioeconomically disadvantaged reproductive-age women, individuals with opioid use disorder, affective disorders) were examined. Participants were randomly assigned to normal nicotine content (NNC; 15.8 mg nicotine/g tobacco) or VLNC (2.4 mg/g or 0.4 mg/g) cigarettes for 12 weeks. Response inhibition (stop-signal task), working memory (<i>n</i>-back task; <i>n</i> of 2-<i>n</i> of 0), and cognitive interference (nicotine Stroop task) were assessed at baseline, 2, 6, and 12 weeks. Results were analyzed using mixed-model repeated-measures analyses of variance. Extended exposure to VLNC cigarettes produced no significant changes in any measure of cognitive performance compared to NNC cigarettes. Over weeks, response times on the <i>n</i>-back task decreased across doses. No significant effects were observed on the stop-signal or nicotine Stroop tasks. All three vulnerable populations performed comparably on all three cognitive tasks. Extended exposure to VLNC cigarettes produced no impairments in cognitive performance on any of the assessed tasks compared to NNC cigarettes. These findings are consistent with the larger literature detailing other consequences following exposure to VLNC cigarettes and are encouraging for the adoption of a nicotine-reduction policy. (PsycInfo Database Record (c) 2024 APA, all rights reserved).</p>","PeriodicalId":12089,"journal":{"name":"Experimental and clinical psychopharmacology","volume":" ","pages":"436-444"},"PeriodicalIF":2.4,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11315237/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140897366","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-08-01Epub Date: 2024-05-09DOI: 10.1037/pha0000723
Meredith S Berry, Kelly E Dunn
Substantial percentages of persons receiving medications for opioid use disorder (MOUD) continue to experience clinically significant levels of pain and opioid withdrawal, which may pose barriers to reducing opioid use. Continued pain, in particular, may increase the risk for psychiatric problems and poorer treatment retention, especially with a lack of adequate care for pain. The goals of these analyses were to characterize the prevalence of, and patient-level variables associated with, pain and opioid withdrawal, as well as utilization of related coping strategies and treatments. Participants were 18 years of age or older and received methadone or buprenorphine for opioid use disorder (n = 179). Participants completed this survey in person, within their MOUD clinic. Participants completed patient-level and demographic questions as well as measures of pain, withdrawal, utilization of related coping strategies, and pain treatment. Numerous participants endorsed chronic pain (41.9%) or opioid withdrawal (89.4%) and indicated reliance upon over-the-counter medications and prayer for pain management. Multiple linear regression models showed greater pain catastrophizing and negative affect accounted for variability in pain severity and pain interference, as well as opioid withdrawal. Persons who slept less and endorsed chronic pain also reported greater pain severity and interference, and pain interference was higher with increased age. These and previous findings combine to further highlight the detrimental role that pain catastrophizing and negative affect can play in pain perception and withdrawal, but also represent promising treatment targets to facilitate pain and withdrawal management and improved quality of life. (PsycInfo Database Record (c) 2024 APA, all rights reserved).
{"title":"Pain and withdrawal are common among patients receiving medications for opioid use disorder and associated with pain catastrophizing, negative affect, and poor sleep.","authors":"Meredith S Berry, Kelly E Dunn","doi":"10.1037/pha0000723","DOIUrl":"10.1037/pha0000723","url":null,"abstract":"<p><p>Substantial percentages of persons receiving medications for opioid use disorder (MOUD) continue to experience clinically significant levels of pain and opioid withdrawal, which may pose barriers to reducing opioid use. Continued pain, in particular, may increase the risk for psychiatric problems and poorer treatment retention, especially with a lack of adequate care for pain. The goals of these analyses were to characterize the prevalence of, and patient-level variables associated with, pain and opioid withdrawal, as well as utilization of related coping strategies and treatments. Participants were 18 years of age or older and received methadone or buprenorphine for opioid use disorder (<i>n</i> = 179). Participants completed this survey in person, within their MOUD clinic. Participants completed patient-level and demographic questions as well as measures of pain, withdrawal, utilization of related coping strategies, and pain treatment. Numerous participants endorsed chronic pain (41.9%) or opioid withdrawal (89.4%) and indicated reliance upon over-the-counter medications and prayer for pain management. Multiple linear regression models showed greater pain catastrophizing and negative affect accounted for variability in pain severity and pain interference, as well as opioid withdrawal. Persons who slept less and endorsed chronic pain also reported greater pain severity and interference, and pain interference was higher with increased age. These and previous findings combine to further highlight the detrimental role that pain catastrophizing and negative affect can play in pain perception and withdrawal, but also represent promising treatment targets to facilitate pain and withdrawal management and improved quality of life. (PsycInfo Database Record (c) 2024 APA, all rights reserved).</p>","PeriodicalId":12089,"journal":{"name":"Experimental and clinical psychopharmacology","volume":" ","pages":"386-391"},"PeriodicalIF":2.4,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11513174/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140897369","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-08-01Epub Date: 2024-02-15DOI: 10.1037/pha0000710
Gabrielle T Maldonado, Christoph Höchsmann, Akansha Anbil, Karissa Neubig, Rabia Imran, Bernard F Fuemmeler, Thokozeni Lipato, Vineela Rachagiri, Andrew J Barnes, Corby K Martin, Caroline O Cobb
Previous work has aimed to disentangle the acute effects of nicotine and smoking on appetite with mixed findings. Electronic nicotine delivery systems (ENDS) have yet to be examined in this regard despite evidence of use for weight control. The present study tested the influence of an ENDS on acute energy intake and associated subjective effects. Participants (n = 34; 18-65 years) with current ENDS use completed two randomly ordered clinical lab sessions after overnight abstinence from tobacco/nicotine/food/drinks (other than water). Sessions differed by the product administered over 20 min: active (20 puffs of a JUUL ENDS device; 5% nicotine tobacco-flavored pod) or control (access to an uncharged JUUL with an empty pod). About 40 min after product administration, participants were provided an ad lib buffet-style meal with 21 food/drink items. Subjective ratings were assessed at baseline, after product use, and before/after the meal. Energy intake (kcal) was calculated using pre-post buffet item weights. Repeated measures analyses of variance and pairwise comparisons were used to detect differences by condition and time (α < .05). Mean ± standard error of the mean energy intake did not differ significantly between active (1011.9 ± 98.8 kcal) and control (939.8 ± 88.4 kcal; p = .108) conditions. Nicotine abstinence symptoms significantly decreased after the active condition, while satiety significantly increased. Following the control condition, satiety remained constant while hunger significantly increased relative to baseline. Findings indicate that acute ENDS use did not significantly impact energy intake, but there was an ENDS-associated subjective increase in satiety and relative decrease in hunger. Results support further investigation of ENDS on appetite. (PsycInfo Database Record (c) 2024 APA, all rights reserved).
{"title":"Initial evidence of the acute effect of electronic nicotine delivery system use on energy intake.","authors":"Gabrielle T Maldonado, Christoph Höchsmann, Akansha Anbil, Karissa Neubig, Rabia Imran, Bernard F Fuemmeler, Thokozeni Lipato, Vineela Rachagiri, Andrew J Barnes, Corby K Martin, Caroline O Cobb","doi":"10.1037/pha0000710","DOIUrl":"10.1037/pha0000710","url":null,"abstract":"<p><p>Previous work has aimed to disentangle the acute effects of nicotine and smoking on appetite with mixed findings. Electronic nicotine delivery systems (ENDS) have yet to be examined in this regard despite evidence of use for weight control. The present study tested the influence of an ENDS on acute energy intake and associated subjective effects. Participants (<i>n</i> = 34; 18-65 years) with current ENDS use completed two randomly ordered clinical lab sessions after overnight abstinence from tobacco/nicotine/food/drinks (other than water). Sessions differed by the product administered over 20 min: active (20 puffs of a JUUL ENDS device; 5% nicotine tobacco-flavored pod) or control (access to an uncharged JUUL with an empty pod). About 40 min after product administration, participants were provided an ad lib buffet-style meal with 21 food/drink items. Subjective ratings were assessed at baseline, after product use, and before/after the meal. Energy intake (kcal) was calculated using pre-post buffet item weights. Repeated measures analyses of variance and pairwise comparisons were used to detect differences by condition and time (α < .05). Mean ± standard error of the mean energy intake did not differ significantly between active (1011.9 ± 98.8 kcal) and control (939.8 ± 88.4 kcal; <i>p</i> = .108) conditions. Nicotine abstinence symptoms significantly decreased after the active condition, while satiety significantly increased. Following the control condition, satiety remained constant while hunger significantly increased relative to baseline. Findings indicate that acute ENDS use did not significantly impact energy intake, but there was an ENDS-associated subjective increase in satiety and relative decrease in hunger. Results support further investigation of ENDS on appetite. (PsycInfo Database Record (c) 2024 APA, all rights reserved).</p>","PeriodicalId":12089,"journal":{"name":"Experimental and clinical psychopharmacology","volume":" ","pages":"465-474"},"PeriodicalIF":2.4,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139734840","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}